Awareness and use of smoking cessation treatments among diabetic patients.

Abstract

AIMS:

To investigate awareness of pharmacotherapeutic aids to smoking cessation in diabetic cigarette smokers.

METHODS:

A structured questionnaire-based interview was held by a research nurse individually with consecutively attending cigarette smokers.

RESULTS:

Of 597 diabetic patients attending a routine clinic, 100 (17%) were current cigarette smokers. Mean (+/-sd) age was 58+/-11 years, 58% were male, and 96% Type 2 diabetic patients. Mean daily cigarette consumption was 16/day, for a mean duration of 35 years. There were 34% who had never heard of nicotine replacement therapy (NRT), and of those who had, only 49% considered it safe with diabetes. Bupropion (Zyban) was unknown to 46%, and of those who knew of it, 39% thought it unsafe in diabetic patients. Only 31% of the group had been previously offered NRT, and 14% bupropion. The NHS Quitline was known of by 84%, but only 8% had used it.

CONCLUSIONS:

Cigarette smokers with diabetes have poor uptake, awareness and knowledge of NRT and bupropion as aids to smoking cessation. They comprise a high-risk group, for large and small vessel disease, and these findings are therefore of concern. More active education and support for these patients by medical and nursing staff is needed.

• Authors: G V Gill, C Morgan, I A MacFarlane
• Journal: Diabetic medicine : a journal of the British Diabetic Association (Diabet Med) Vol. 22 Issue 5 Pg. 658-60 (May 2005) ISSN: 0742-3071 [Print] England
• PMID: 15842526 (Publication Type: Journal Article)

Chemical References

• Antidepressive Agents, Second-Generation
• Bupropion
• Nicotine

Topics

• Aged
• Antidepressive Agents, Second-Generation (therapeutic use)
• Bupropion (therapeutic use)
• Diabetes Mellitus, Type 2
• Female
• Health Behavior
• Health Knowledge, Attitudes, Practice
• Humans
• Male
• Middle Aged
• Nicotine (administration & dosage)
• Smoking Cessation (methods)
• Smoking Prevention
• Surveys and Questionnaires